Functional Medicine: Finding the Root Cause of Illness

Quick Answer
Functional Medicine is a whole-person, systems biology approach that identifies how genetics, environment, nutrition, lifestyle, and psychosocial stressors may interact to drive chronic illness. Rather than treating disease labels in isolation, practitioners evaluate patterns of dysfunction across interconnected body systems — including mitochondrial metabolism, the hypothalamic-pituitary-adrenal (HPA) axis, gut microbiome composition, and immune signalling — to address upstream contributors where clinically appropriate (1-4).
At a Glance
- Functional Medicine applies systems biology and network medicine principles to identify upstream drivers of chronic symptoms, rather than focusing solely on disease labels (1-5).
- Chronic illness may involve interacting metabolic, immune, hormonal, and neurological stressors that fall below standard pathology diagnostic thresholds (3,5).
- Mitochondrial dysfunction, as described in Robert Naviaux’s Cell Danger Response model, has been associated with fatigue-dominant conditions (6,7).
- Changes in intestinal permeability and microbial composition may contribute to systemic immune activation, according to research by Alessio Fasano and colleagues (10-12).
- Advanced functional testing such as organic acids testing (OAT) and comprehensive stool analysis can reveal metabolic patterns not captured by standard blood panels (6,7,25).
- The approach integrates peer-reviewed research and is complementary to conventional medical care, not oppositional to it (2,4).
Moving Beyond a Symptom-Only Model
Albert-Laszlo Barabasi’s network medicine framework has demonstrated that chronic disease rarely arises from a single gene or pathway, but instead reflects interconnected disturbances across multiple biological networks (5). In our Adelaide clinic at Elemental Health and Nutrition, many patients describe persistent fatigue, pain, or physiological imbalance despite being told their blood tests fall “within normal range.” While conventional medicine plays a critical role in acute care and disease management, chronic conditions frequently involve multi-system dysfunction that may not reach diagnostic thresholds on standard pathology.
Functional Medicine is a systems-based, evidence-informed approach that aims to identify contributing physiological drivers of chronic symptoms, rather than focusing solely on isolated clinical findings. The Institute for Functional Medicine (IFM) has formalised this methodology through structured clinical frameworks that guide practitioners in exploring root-cause contributors.
Chronic illness rarely arises from a single isolated abnormality. Research into complex disease models suggests that persistent symptoms often reflect interacting metabolic, immune, hormonal, and neurological stressors, rather than a single discrete pathology (3,5).
In clinical education, commonly cited examples include:
- Lipid-lowering therapy improving cholesterol markers without addressing metabolic contributors such as insulin resistance or inflammatory signalling
- Short-term digestive symptom relief without identifying contributing factors such as microbial imbalance, nutrient insufficiency, or immune activation
Functional Medicine applies structured clinical questioning to explore why dysfunction may be occurring, while remaining complementary — not oppositional — to conventional medical care (2,4).
Common Contributing Drivers Explored in Chronic Illness
Multi-system dysfunction in chronic illness may involve several interacting biological domains, each supported by distinct bodies of peer-reviewed research.
| Contributing Driver | Biological Mechanism | Associated Conditions | Key References |
|---|---|---|---|
| Mitochondrial and Energy Metabolism | Altered cellular energy production via the electron transport chain; Robert Naviaux’s Cell Danger Response (CDR) model | Chronic fatigue and unexplained symptoms | (6,7) |
| Environmental and Toxicant Exposure | Oxidative stress, impaired cytochrome P450 detoxification pathways, glutathione depletion | Chemical sensitivity, neurological symptoms in susceptible individuals | (8,9) |
| Gut Function and Microbiome Balance | Altered intestinal permeability (Alessio Fasano’s zonulin pathway), microbial dysbiosis, short-chain fatty acid imbalance | Gut dysfunction and microbiome imbalance, autoimmune conditions | (10-12) |
| Hormonal Regulation | Dysregulation of insulin signalling, thyroid hormone conversion (T4 to T3), and the HPA axis stress response | Thyroid and hormonal dysfunction, metabolic syndrome | (13-15) |
| Psychophysiological Stress Load | Bruce McEwen’s allostatic load model; Stephen Porges’ polyvagal theory; autonomic imbalance and inflammatory signalling via neuroendocrine pathways | Stress-related conditions, autonomic dysfunction, chronic inflammation | (16-18) |
Clinical Pattern Recognition: Asking Better Questions
Functional Medicine emphasises pattern recognition over symptom isolation, using clinical observations across interconnected physiological systems to guide further investigation rather than to establish diagnoses in isolation.
| Nutrient or Metabolite | Physiological Role | Clinical Significance | Key References |
|---|---|---|---|
| Zinc | Immune signalling (NF-kB pathway modulation), digestive enzyme cofactor, over 300 enzymatic reactions | Suboptimal intake or absorption may contribute to immune dysfunction; Wessels et al. described zinc as a “gatekeeper of immune function” | (19,20) |
| Vitamin B12 | Methylation cycle cofactor, myelin sheath maintenance, homocysteine metabolism | Insufficiency associated with fatigue, balance disturbances, and neurocognitive symptoms, particularly in vegetarian, elderly, and malabsorption-risk populations | (21,22) |
| Oxalate handling | Oxalate metabolism via glyoxylate pathway; renal and systemic crystal deposition | Impaired oxalate metabolism discussed in relation to renal and musculoskeletal symptoms; evidence remains evolving per Lorenz et al. | (23,24) |
Advanced Functional Testing (When Clinically Indicated)
Validated specialty testing may complement standard pathology by revealing functional metabolic patterns that routine blood panels do not assess. When appropriate, Functional Medicine practitioners may utilise the following approaches:
| Test Type | What It Assesses | Clinical Application |
|---|---|---|
| Comprehensive stool analysis | Digestive markers, microbial diversity, short-chain fatty acids, calprotectin, secretory IgA | Identifying dysbiosis, inflammatory markers, and digestive insufficiency (10-12) |
| Environmental exposure screening | Heavy metals, organophosphates, volatile solvents | When clinical history suggests environmental toxicant burden (8,9) |
| Organic acids testing (OAT) | Krebs cycle intermediates, neurotransmitter metabolites, nutrient cofactor markers | Assessing mitochondrial function, methylation status, and nutrient pathways (6,7,25) |
Testing is selected based on clinical relevance and is not used as a stand-alone diagnostic tool.
Next Steps
- Reflect on your symptom patterns: Consider whether your symptoms involve multiple body systems — fatigue, digestion, mood, hormones — rather than a single isolated issue. Multi-system patterns often respond to a systems-based approach.
- Review your testing history: If standard blood tests have returned “normal” but symptoms persist, targeted functional testing may help identify contributing factors that standard pathology does not assess.
- Book a discovery session: A structured Functional Medicine consultation can help determine whether upstream metabolic, immune, or hormonal contributors may be involved in your presentation.
Frequently Asked Questions
Key Insights
- Functional Medicine explores upstream contributors, not only downstream symptoms
- Chronic illness commonly reflects multi-system interaction, rather than single-cause pathology
- Care is individualised, evidence-informed, and complementary
- Advanced testing is applied selectively and contextually
Citable Takeaways
- Functional Medicine applies systems biology and network medicine principles to identify upstream metabolic, immune, hormonal, and neurological contributors to chronic illness, rather than treating symptoms in isolation (Bland, 2019; Hanaway, 2016).
- Barabasi et al. demonstrated that human disease operates through interconnected biological networks, supporting a multi-system approach to chronic conditions rather than single-target interventions (Barabasi, Gulbahce & Loscalzo, 2011).
- Robert Naviaux’s Cell Danger Response model suggests that mitochondrial dysfunction may underlie fatigue-dominant chronic conditions by altering cellular energy metabolism through the electron transport chain (Naviaux, 2014).
- Alessio Fasano’s research on intestinal permeability and the zonulin pathway has linked altered gut barrier function to immune activation and autoimmune processes, supporting the role of microbiome assessment in chronic illness evaluation (Fasano, 2012).
- Bruce McEwen’s allostatic load framework describes how chronic psychophysiological stress may contribute to autonomic imbalance and inflammatory signalling, providing a physiological basis for stress-related multi-system dysfunction (McEwen, 1998).
- Wessels, Maywald, and Rink characterised zinc as a “gatekeeper of immune function,” with suboptimal status potentially contributing to immune dysregulation across over 300 enzymatic reactions (Wessels et al., 2017).
Find the Root of Your Chronic Symptoms
If you are experiencing persistent symptoms despite “normal” results, a Functional Medicine approach may help clarify what is being missed. At Elemental Health and Nutrition, Rohan Smith works with complex chronic presentations to identify the upstream contributors that standard testing often overlooks.
References
- Bland JS. Systems Biology Meets Functional Medicine. Integr Med (Encinitas). 2019 May;18(2):8-13. https://pmc.ncbi.nlm.nih.gov/articles/PMC7219445
- Hanaway P. Form Follows Function: A Functional Medicine Overview. Perm J. 2016 Fall;20(4):15-242. https://doi.org/10.7812/TPP/15-242
- Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011 Apr;8(4):184-7. https://doi.org/10.1038/nrclinonc.2011.12
- Weston AD, Hood L. Systems biology, proteomics, and the future of health care. J Proteome Res. 2004;3(2):179-96. https://doi.org/10.1021/pr049930s
- Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011 Jan;12(1):56-68. https://doi.org/10.1038/nrg2918
- Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014 May;16:7-17. https://doi.org/10.1016/j.mito.2013.08.006
- Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer. Annu Rev Genet. 2005;39:359-407. https://doi.org/10.1146/annurev.genet.39.110304.095751
- Pizzorno J. Environmental toxicants: lead and mercury. Integr Med (Encinitas). 2015 Jun;14(3):8-14.
- Genuis SJ. Elimination of persistent toxicants from the human body. Sci World J. 2011;11:482-5. https://doi.org/10.1100/tsw.2011.59
- Quigley EMM. Gut bacteria in health and disease. Gastroenterol Hepatol (N Y). 2013 Sep;9(9):560-9.
- Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012 Feb;42(1):71-8. https://doi.org/10.1007/s12016-011-8291-x
- Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016 Feb;65(2):330-9. https://doi.org/10.1136/gutjnl-2015-309990
- Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014 Apr;94(2):355-82. https://doi.org/10.1152/physrev.00030.2013
- Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005;67:259-84. https://doi.org/10.1146/annurev.physiol.67.040403.120816
- Tsigos C, Kyrou I, Vgontzas AN, Chrousos GP. Stress, visceral obesity, and the metabolic syndrome. Ann N Y Acad Sci. 2010;1216:1-14.
- McEwen BS. Stress, adaptation, and disease: allostasis and allostatic load. Ann N Y Acad Sci. 1998 May 1;840:33-44. https://doi.org/10.1111/j.1749-6632.1998.tb09546.x
- Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000 Dec;61(3):201-16.
- Porges SW. The polyvagal theory: new insights into adaptive reactions of the autonomic nervous system. Cleve Clin J Med. 2009 Apr;76 Suppl 2:S86-90. https://doi.org/10.3949/ccjm.76.s2.17
- Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in antiviral immunity. Adv Nutr. 2019 Jul 1;10(4):696-710. https://doi.org/10.1093/advances/nmz013
- Wessels I, Maywald M, Rink L. Zinc as a Gatekeeper of Immune Function. Nutrients. 2017 Nov 25;9(12):1286. https://doi.org/10.3390/nu9121286
- Hunt A, Harrington D, McCaddon A. Vitamin B12 deficiency. BMJ. 2014 Sep 4;349:g5226. https://doi.org/10.1136/bmj.g5226
- O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010 Mar;2(3):299-316. https://doi.org/10.3390/nu2030299
- Lorenz EC, Michet CJ Jr, Milliner DS, Lieske JC. Update on oxalate crystal disease. Curr Rheumatol Rep. 2013 Jul;15(7):340.
- Knight J, Assimos DG, Callahan MF, Holmes RP. Metabolism of primed, constant infusions of glycine and phenylalanine to urinary oxalate. Metabolism. 2011 Feb;60(2):278-89.
- Bralley JA, Lord RS. Treatment of chronic fatigue syndrome with specific amino acid supplementation. J Am Nutraceut Assoc. 1999;2(4):1-8.
